Core Insights - Colgate-Palmolive Company reported a decline in net sales for Q4 2024, missing the Zacks Consensus Estimate, while earnings per share (EPS) improved and exceeded expectations [1][2][3] Financial Performance - Net sales were $4,944 million, down 0.1% from $4,950 million in the previous year, and missed the consensus estimate of $4,987 million [3] - On an organic basis, sales grew by 4.3%, driven by a 2.5% increase in volume and a 1.8% improvement in pricing [4] - Gross profit increased to $2,982 million from $2,950 million year-over-year, with a gross profit margin expansion of 70 basis points to 60.3% [6] - Operating profit was $1,064 million, a slight decrease from $1,072 million in the prior year, with an operating profit margin contraction of 20 basis points to 21.5% [7] Market Position - Colgate maintained a leading position in the toothpaste market with a 41.4% global market share and a 32.2% share in the manual toothbrush market [5] Regional Performance - North America saw a 1% decline in net sales, while Latin America experienced a 7.2% decline due to unfavorable currency impacts, despite organic sales growth of 9.2% [8] - Europe’s net sales increased by 4.9%, driven by volume and pricing gains [9] - The Asia Pacific segment improved by 3.7% year-over-year, with a notable 5.8% increase in volume [10] - Africa/Eurasia's net sales rose by 2.8%, supported by an 11.5% increase in volume [10] - Hill's Pet Nutrition's net sales improved by 2.3% on a reported basis [11] Cash Flow and Shareholder Returns - The company ended Q4 2024 with cash and cash equivalents of $1,096 million and total debt of $7,949 million [12] - Net cash provided by operating activities was $4,107 million for the year, with $3.4 billion returned to shareholders through dividends and share repurchases [12] 2025 Outlook - Colgate expects flat net sales in 2025, with organic sales growth projected between 3% to 5% [14] - The company anticipates gross profit margin expansion and mid-single-digit growth in Base Business EPS for 2025 [15][16]

Group 1 - Colgate-Palmolive (CL) shares fell 5% after missing revenue forecasts and providing weak guidance due to foreign exchange impacts [1][5] - The company reported a revenue decline of 0.1% to $4.94 billion, missing the anticipated $4.98 billion [1][5] - Adjusted earnings per share (EPS) of $0.91 exceeded forecasts [1] Group 2 - Foreign exchange rates negatively impacted revenue by 4.4%, with Latin America experiencing a sales slump of 7.2% [2] - Sales in North America decreased by 1.0%, while Europe, Asia-Pacific, and Africa/Eurasia saw increases of 4.9%, 3.7%, and 2.8% respectively [2] - Sales at Hill's, which represents the largest percentage of total revenue, rose by 2.3% [2] Group 3 - CEO Noel Wallace stated that the company met its goals for the year, focusing on peer-leading growth and future investment [3] - For 2025, Colgate expects revenue to be "roughly flat" from 2024's $20.1 billion, anticipating a mid-single-digit negative impact from foreign exchange [3] - Visible Alpha estimates for 2025 revenue were $20.3 billion [3] Group 4 - Despite the recent drop, Colgate-Palmolive shares remain slightly higher over the past year [4]

Group 1 - The article emphasizes a dividend-focused value investment strategy that prioritizes capital preservation and steady income growth [1] - The author discusses a diversified dividend stock portfolio that includes high-quality value stocks with meaningful growth potential and long-term safety [1] Group 2 - There are no current stock or derivative positions in any mentioned companies, and no plans to initiate such positions in the near term [2] - The author may consider initiating a long position in Colgate-Palmolive Company through the sale of put options within the next 72 hours [3]

Colgate-Palmolive (CL) reported $4.94 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 0.1%. EPS of $0.91 for the same period compares to $0.87 a year ago.The reported revenue represents a surprise of -0.86% over the Zacks Consensus Estimate of $4.99 billion. With the consensus EPS estimate being $0.89, the EPS surprise was +2.25%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...

Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.25%. A quarter ago, it was expected that this consumer products maker would post earnings of $0.88 per share when it actually produced earnings of $0.91, delivering a surprise of 3.41%.Over the last four quarters ...

COLGATE-PALMOLIVE COMPANY 4Q & FULL YEAR 2024 EARNINGS PRESENTATION TIGHTLY FOCUSED ON FOUR ATTRACTIVE CORE CATEGORIES ORAL CARE PET NUTRITION JANUARY 31, 2025 January 2025 Notice for Investor Presentation Please review the following fourth quarter and full year 2024 earnings presentation in conjunction with our fourth quarter and full year 2024 earnings press release, our fourth quarter and full year 2024 prepared management remarks and additional information regarding our non-GAAP financial measures, incl ...

Exhibit 99 Colgate Announces 4th Quarter and Full Year 2024 Results Full Year | Full Year Total Company Results (GAAP) | | | | | --- | --- | --- | --- | | ($ in millions except per share amounts) | 2024 | 2023 | Change | | Net Sales | $20,101 | $19,457 | +3.3 % | | EPS (diluted) | $3.51 | $2.77 | +27 % | | Full Year Total Company Results (Base Business - Non-GAAP)* | | | | | --- | --- | --- | --- | | ($ in millions except per share amounts) | 2024 | 2023 | Change | | Organic Sales Growth | | | +7.4 % | | Ba ...

Colgate-Palmolive Company CL will release earnings results for its fourth quarter before the opening bell on Friday, Jan. 31, 2025.Analysts expect the New York-based company to report quarterly earnings at 89 cents per share, up from 87 cents per share in the year-ago period. Colgate-Palmolive projects to report revenue of $4.99 billion for the recent quarter, compared to $4.95 billion a year earlier, according to data from Benzinga Pro.On Dec. 11, the company's Board of Directors declared a quarterly cash ...

Core Viewpoint - Colgate-Palmolive Company (CL) is anticipated to report growth in both revenue and earnings for the fourth quarter of 2024, with revenue expected to reach $5 billion, reflecting a 1.2% increase year-over-year, and earnings estimated at 89 cents per share, indicating a 2.3% growth from the previous year [1][2]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for fourth-quarter revenues is $5 billion, up 1.2% from the same quarter last year [1]. - The consensus estimate for earnings is 89 cents per share, suggesting a growth of 2.3% year-over-year [2]. Earnings Performance - In the last reported quarter, Colgate's earnings exceeded the consensus estimate by 3.4%, with an average earnings surprise of 3.8% over the trailing four quarters [2]. Earnings Prediction Model - The current Earnings ESP for Colgate is -0.91%, and it holds a Zacks Rank of 3 (Hold), indicating that the model does not predict a definitive earnings beat this season [3]. Business Momentum and Growth Drivers - Colgate's fourth-quarter performance is expected to benefit from strong business momentum, pricing strategies, and productivity initiatives, with a focus on balanced organic sales growth across all categories [4]. - The company is projected to achieve organic sales growth of 6.5%, with significant improvements in various regions, including 12% in Latin America and 9% in Europe [5]. Gross Margin and Profitability - The adjusted gross margin is expected to expand by 210 basis points to 61.7%, with a 5.6% year-over-year increase in adjusted gross profit [7]. - Colgate has been experiencing a sequential rise in gross margin due to strong pricing and revenue growth management initiatives [6]. Challenges and Headwinds - The company faces challenges such as volume softness in China and lower private label growth, which may slightly impact top-line performance [8]. - Higher raw material costs and inflationary foreign exchange pressures are also expected to offset some gross margin growth [9]. SG&A Expenses - SG&A expenses are anticipated to rise by 6.9% year-over-year, reaching 38.2% of sales, reflecting continued investment in digital and analytics capabilities [10]. Stock Performance and Valuation - Colgate's shares have increased by 8.7% over the past year, outperforming the broader industry growth of 0.9% but underperforming the S&P 500 index, which grew by 24.8% [11]. - The stock trades at a forward P/E multiple of 24.04X, higher than the industry average of 21.43X and the S&P 500's average of 22.64X, indicating a relatively pricey valuation [14].

Stock Performance - Colgate-Palmolive Company (CL) shares appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer Products – Staples industry's rise of 6% and the broader Zacks Consumer Staples sector's return of 0.2% [1] - The upswing was driven by strong pricing, funding-the-growth initiatives, and solid business momentum, leading to robust performance in Q3 2024 [3] Financial Metrics - Adjusted gross margin rose to 61.3% and adjusted operating profit margin increased to 21.5% in Q3 2024 [4] - Year-over-year earnings per share growth was achieved, driven by higher gross margins and improved pricing across all divisions except North America [5] - Organic sales growth was bolstered by increased volume and pricing, with every operating division reporting volume growth for the second consecutive quarter [5] Strategic Initiatives - The company's strategy of combining core and premium innovation with increased advertising investment and enhanced capabilities is driving brand strength and expanding household penetration [6] - Successful product launches include CO by Colgate, Colgate Elixir toothpaste, and Colgate enzyme whitening toothpaste [6] Outlook and Guidance - Management forecasts gross profit margin expansion on both GAAP and adjusted bases, driven by pricing gains and revenue-growth management initiatives [7] - Base Business's EPS is expected to increase 10-11% in 2024, with GAAP EPS rising by double digits [7] - Net sales growth is anticipated at 3-5%, with organic sales growth expected at 7-8% for 2024 [8] - Currency translations are expected to have a mid-single-digit negative impact on sales [8] Revised Estimates - The Zacks Consensus Estimate for CL's fiscal 2024 earnings has remained unchanged in the past 30 days [9] - For 2024, sales and EPS are expected to grow 3.9% and 11.2% year-over-year, respectively [9] - For 2025, sales and earnings are expected to grow 3.1% and 6.7% year-over-year, respectively [9] Challenges - The company faces macroeconomic instability and foreign currency headwinds [10] - Persistent inflation in raw materials and packaging costs has negatively impacted profitability [10] - North America's net sales dipped 1.9% year-over-year on an organic basis, with a 3.2% decrease in pricing offset by a 1.2% increase in volume [11] - Latin America's net sales fell 3.2% year-over-year due to unfavorable currency impacts [11] - Foreign currency fluctuations reduced total sales growth by 4.4% in Q3, with significant effects from Argentina and the Africa/Eurasia division [12] Final Thoughts - CL's robust pricing strategies, productivity initiatives, and innovations make the stock attractive for long-term investors [13] - Continuing challenges like macroeconomic instability and foreign currency headwinds act as deterrents, suggesting current investors retain their positions while new investors wait for a more favorable entry point [14]